Brenntag Specialties signs a strategic partnership agreement with Aker BioMarine for Southeast Asia

Brenntag, the global market leader in chemicals and ingredients distribution, announced the signing of the distribution agreement with Aker BioMarine, covering health supplements such as Superba 2, Superba 2 Halal, Superba Boost, and Antarctic Krill Oil 2.

Aker BioMarine is a biotech innovator and Antarctic krill harvesting company dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world.

Superba Krill oil, an Aker BioMarine product, is a next-generation phospholipid-complex, with omega-3s and choline. The natural combination of multiple nutrients offers a wide range of clinically proven health benefits to match the needs of health-conscious consumers. Powered by phospholipids, Superba Krill ensures that omega-3s EPA & DHA and choline are delivered to parts of the body that need them the most, such as the brain, heart, eyes, and liver. Superba Krill oil is pure, sustainable, and traceable, backed by more than 50 human studies.

Ross Norris, general manager Asia Pacific, Aker BioMarine said, "We are thrilled to announce our strategic partnership with Brenntag Specialties, marking a significant step forward in our mission to serve the nutraceutical segment in Southeast Asia. This distribution agreement underscores our commitment to providing high-quality, sustainable Antarctic Krill oil products to customers in the region. Through this collaboration, we aim to enhance human health and well-being by offering innovative solutions backed by scientific research. We look forward to leveraging Brenntag's extensive network and expertise to bring our products to a broader audience and make a positive impact on the health and vitality of consumers across Southeast Asia."

"We are delighted to enter this strategic partnership with Aker BioMarine which sets sustainability and health at the heart of their values. Aker BioMarine solutions are innovative, clinically proven, and have multiple health benefits and we will use all our expertise and capabilities to bring these complementary solutions to our customers and consumers across Southeast Asia. This agreement reinforces Brenntag Specialties’ complementary medicines offering in Southeast Asia and affirms our focus on pharmaceutical and nutraceutical solutions across the APAC region," said Romain Girard, regional president, Pharma Asia Pacific, Brenntag Specialties.